Total Payments
$30,422
2024 Payments
$4,108
Companies
69
Transactions
1,222
Medicare Patients
6,817
Medicare Billing
$723,411
Payment Breakdown by Category
Food & Beverage$23,745 (78.1%)
Education$6,463 (21.2%)
Travel$161.48 (0.5%)
Consulting$52.95 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,745 | 1,202 | 78.1% |
| Education | $6,463 | 16 | 21.2% |
| Travel and Lodging | $161.48 | 2 | 0.5% |
| Consulting Fee | $52.95 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $6,275 | 6 | $0 (2022) |
| GlaxoSmithKline, LLC. | $3,003 | 208 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,929 | 128 | $0 (2024) |
| GENZYME CORPORATION | $1,512 | 42 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,475 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,426 | 79 | $0 (2024) |
| Grifols USA, LLC | $1,054 | 58 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $847.43 | 38 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $842.63 | 49 | $0 (2024) |
| Insmed, Inc. | $793.37 | 61 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,108 | 187 | AstraZeneca Pharmaceuticals LP ($705.63) |
| 2023 | $4,009 | 189 | GlaxoSmithKline, LLC. ($607.43) |
| 2022 | $9,942 | 180 | Intuitive Surgical, Inc. ($6,275) |
| 2021 | $2,615 | 124 | GlaxoSmithKline, LLC. ($302.03) |
| 2020 | $2,090 | 124 | GlaxoSmithKline, LLC. ($335.95) |
| 2019 | $3,028 | 170 | AstraZeneca Pharmaceuticals LP ($417.23) |
| 2018 | $2,399 | 135 | AstraZeneca Pharmaceuticals LP ($453.27) |
| 2017 | $2,231 | 113 | GlaxoSmithKline, LLC. ($350.09) |
All Payment Transactions
1,222 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Pulmonology | ||||||
| 12/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: CRITICAL CARE | ||||||
| 12/17/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: CRITICAL CARE | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Immunology and Neurology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/21/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.79 | General |
| Category: HFCWO | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,584 | 2,225 | $442,619 | $168,435 |
| 2022 | 19 | 1,667 | 2,272 | $401,791 | $170,195 |
| 2021 | 23 | 1,656 | 2,360 | $487,370 | $187,573 |
| 2020 | 22 | 1,910 | 2,705 | $512,881 | $197,207 |
Total Patients
6,817
Total Services
9,562
Medicare Billing
$723,411
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 444 | 666 | $83,395 | $39,990 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 267 | 391 | $71,281 | $34,605 | 48.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 334 | $69,806 | $30,484 | 43.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 97 | $54,902 | $15,719 | 28.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 98 | $33,418 | $12,755 | 38.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 90 | 92 | $13,476 | $6,392 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $11,603 | $4,959 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 31 | $7,542 | $4,046 | 53.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $7,478 | $3,255 | 43.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 95 | 98 | $3,332 | $2,772 | 83.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 45 | $6,390 | $2,731 | 42.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 95 | 103 | $10,403 | $2,490 | 23.9% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 13 | 14 | $16,198 | $1,837 | 11.3% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 16 | 18 | $28,224 | $1,317 | 4.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 33 | 33 | $6,039 | $1,216 | 20.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 32 | 32 | $3,936 | $1,131 | 28.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 38 | 38 | $6,612 | $957.98 | 14.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 33 | 37 | $4,292 | $885.24 | 20.6% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 15 | 17 | $4,007 | $861.05 | 21.5% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 15 | 15 | $285.00 | $32.48 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 437 | $74,727 | $38,642 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 419 | 580 | $66,120 | $35,561 | 53.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 114 | 328 | $68,552 | $25,449 | 37.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 53 | 113 | $63,958 | $18,610 | 29.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 95 | 98 | $33,418 | $14,440 | 43.2% |
About Dr. Stephen Chitty, MD
Dr. Stephen Chitty, MD is a Pulmonary Disease healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902895824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Chitty, MD has received a total of $30,422 in payments from pharmaceutical and medical device companies, with $4,108 received in 2024. These payments were reported across 1,222 transactions from 69 companies. The most common payment nature is "Food and Beverage" ($23,745).
As a Medicare-enrolled provider, Chitty has provided services to 6,817 Medicare beneficiaries, totaling 9,562 services with total Medicare billing of $723,411. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Brunswick, GA
- Active Since 10/14/2005
- Last Updated 01/05/2026
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1902895824
Products in Payments
- ION (Device) $6,000
- DUPIXENT (Biological) $2,768
- TRELEGY ELLIPTA (Drug) $1,193
- NUCALA (Biological) $1,012
- OFEV (Drug) $914.52
- ACTHAR (Biological) $871.09
- Arikayce (Drug) $793.37
- TEZSPIRE (Biological) $729.71
- OPSUMIT (Drug) $530.66
- SYMBICORT (Drug) $510.08
- FASENRA (Biological) $503.11
- Prolastin-C Liquid (Biological) $498.17
- Yupelri (Drug) $449.96
- LONHALA MAGNAIR (Drug) $437.56
- FASENRA (Drug) $415.74
- Xolair (Biological) $398.36
- Xembify (Biological) $376.81
- (8874) inCourage (Device) $338.59
- GENERAL - BRONCHIAL THERMOPLASTY (Device) $331.69
- Hizentra (Biological) $328.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Brunswick
Coleman Sudduth, M.d, M.D
Pulmonary Disease — Payments: $30,269
Pulmonary Disease $30,269
Dr. Evan Fountain, M.d, M.D
Pulmonary Disease — Payments: $12,464
Pulmonary Disease $12,464
Dr. Donald Woloszyn, Md, MD
Pulmonary Disease — Payments: $11,621
Pulmonary Disease $11,621
Herman Levy, M.d, M.D
Pulmonary Disease — Payments: $6,835
Pulmonary Disease $6,835
Dr. Hal Sreden, Md, MD
Pulmonary Disease — Payments: $4,517
Pulmonary Disease $4,517
Ryan Goetz, Md, MD
Pulmonary Disease — Payments: $899.86
Pulmonary Disease $899.86